New guidelines for the clinical management of febrile neutropenia and sepsis in pediatric oncology patients

被引:0
|
作者
Almeida Mendes, Ana Verena [1 ,2 ]
Sapolnik, Roberto [3 ]
Mendonca, Nubia [4 ]
机构
[1] Univ Sao Paulo, Sao Paulo, SP, Brazil
[2] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil
[3] Univ Fed Bahia, Salvador, BA, Brazil
[4] Sociedade Oncol Bahia ONCO, Ser Oncol Pediat, Salvador, BA, Brazil
关键词
D O I
10.2223/JPED.1624
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives: To provide a foundation for the diagnostic, prophylactic and therapeutic management of febrile neutropenia and sepsis in children with oncological diseases, with special attention to new protocols and guidelines. Sources: A review of the scientific literature utilizing an electronic bibliographic search on MEDLINE, Medscape, SciELO, Google, Cochrane and PubMED using the keywords febrile, neutropenic, cancer, children, sepsis, intensive, care. Articles published between 1987 and 2007 were selected, with preference given to review articles, protocols, systematic reviews, epidemiological studies, task force recommendations and phase III clinical trials. Consensus documents published by the Infectious Diseases Society of America, the Center for Diseases Control and the Infectious Diseases Working Party of the German Society of Hematology and Oncology, in addition to the recommendations of the World Federation of Pediatric Intensive and Critical Care Societies and Society of Critical Care Medicine, were also reviewed. Summary of the findings: The use of aggressive chemotherapy regimens, bone marrow transplantation and intensive care resources have increased the survival rates of children with cancer and also their infectious morbidity, with septic complications as the principal cause of mortality. Several risk factors have been identified, such as neutropenia, oncology type, clinical signs and inflammatory response markers (polymerase chain reaction, procalcitonin) and also increased resistance to antimicrobials and antifungal agents. Protocols for risk classification, diagnosis and treatment should be established at each service, taking into account the microbiological flora of each population. Pediatric intensive care has increased the short and long-term survival of these patients. Conclusions: Oncology patients are particularly vulnerable to infectious complications. Early identification and treatment are fundamental to improving survival rates.
引用
收藏
页码:S54 / S63
页数:10
相关论文
共 50 条
  • [1] Management of Febrile Neutropenia in Pediatric Oncology Patients in Central Texas
    Wittenburg, Karen
    Bui, Ashley
    Lipsitt, Amanda
    Fernandez, Marisol
    Fowler, Amy
    Merkel, Kathryn
    Cuellar, Kim
    [J]. PEDIATRIC BLOOD & CANCER, 2017, 64 : S62 - S62
  • [2] Management of febrile neutropenia in pediatric oncology patients: A Canadian survey
    Boragina, Mariana
    Patel, Herna
    Reiter, Stephanie
    Dougherty, Geoffrey
    [J]. PEDIATRIC BLOOD & CANCER, 2007, 48 (05) : 521 - 526
  • [3] Diagnosis and Management of Febrile Neutropenia in Pediatric Oncology Patients-A Systematic Review
    Boeriu, Estera
    Borda, Alexandra
    Dumitru Vulcanescu, Dan
    Sarbu, Vlad
    Teodora Arghirescu, Smaranda
    Ciorica, Ovidiu
    Bratosin, Felix
    Marincu, Iosif
    George Horhat, Florin
    [J]. DIAGNOSTICS, 2022, 12 (08)
  • [4] Italian guidelines for the management of infectious complications in pediatric oncology: Empirical antimicrobial therapy of febrile neutropenia
    Viscoli, C
    Castagnola, E
    Caniggia, M
    De Sio, L
    Garaventa, A
    Giacchino, M
    Indolfi, P
    Izzi, GC
    Manzoni, P
    Rossi, MR
    Santoro, N
    Zanazzo, GA
    Masera, G
    [J]. ONCOLOGY, 1998, 55 (05) : 489 - 500
  • [5] Management of febrile neutropenia: ESMO Clinical Practice Guidelines
    de Naurois, J.
    Novitzky-Basso, I.
    Gill, M. J.
    Marti, F. Marti
    Cullen, M. H.
    Roila, F.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : v252 - v256
  • [6] Evaluation of the clinical Index of Stable febrile neutropenia risk stratification system for management of febrile neutropenia in gynecologic oncology patients
    Monuszko, Karen A.
    Albright, Benjamin
    De Oca, Mary Katherine Montes
    Nguyen Thao Thi Nguyen
    Havrilesky, Laura J.
    Davidson, Brittany A.
    [J]. GYNECOLOGIC ONCOLOGY REPORTS, 2021, 37
  • [7] FEBRILE NEUTROPENIA IN PEDIATRIC ONCOLOGY: A REGIONAL QUALITY IMPROVEMENT STUDY OF GUIDELINES FOR FEBRILE NEUTROPENIA UPTAKE AND TARGETED KNOWLEDGE TRANSLATION
    Price, V.
    Bernstein, M.
    MacDonald, T.
    Digout, C.
    Johnson, C.
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 : S389 - S389
  • [8] Management of febrile neutropenia in canine and feline oncology patients
    Harper, Aaron
    [J]. IN PRACTICE, 2022, 44 (09) : 513 - 519
  • [9] Increased interleukin-10 levels correlate with bacteremia and sepsis in febrile neutropenia pediatric oncology patients
    Urbonas, Vincas
    Eidukaite, Audrone
    Tamuliene, Indre
    [J]. CYTOKINE, 2012, 57 (03) : 313 - 315
  • [10] READMISSION FOLLOWING HOSPITALIZATION FOR FEBRILE NEUTROPENIA IN PEDIATRIC ONCOLOGY PATIENTS
    Kalpatthi, Ram
    McCormick, Meghan
    Richardson, Troy
    [J]. PEDIATRIC BLOOD & CANCER, 2021, 68 : S38 - S38